These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 13066241)
1. [Results of triethylene melanine therapy of Hodgkin's disease and of chronic myeloid leukemia; preliminary communication]. GARCIGA CE Arch Cuba Cancerol; 1953; 12(1-6):39-46. PubMed ID: 13066241 [No Abstract] [Full Text] [Related]
2. The clinical use of triethylene melamine. KRAVITZ SC; DIAMOND HD; CRAVER LF Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758 [No Abstract] [Full Text] [Related]
3. Myleran and triethylene melamine in the treatment of chronic granulocytic leukemia. BETHELL FH Ann N Y Acad Sci; 1958 Apr; 68(3):996-1000. PubMed ID: 13627746 [No Abstract] [Full Text] [Related]
4. Unusual toxicity to triethylene melamine in a case of chronic myelogenous leukemia. SLIPYAN A Ann Intern Med; 1953 Feb; 38(2):331-5. PubMed ID: 13017443 [No Abstract] [Full Text] [Related]
6. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia]. NEUMANN C Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980 [No Abstract] [Full Text] [Related]
7. [Treatment of hemoblastosis with triethylene melamine]. LINKE A; LASCH HG Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032 [No Abstract] [Full Text] [Related]
8. Treatment of lymphomatous diseases with triethylene melamine. MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963 [No Abstract] [Full Text] [Related]
9. TRIETHYLENE MELAMINE IN THE CONTROL OF HODGKIN'S DISEASE AND THE LEUKEMIAS. IV. CLINICAL REPORTS, 1959-62. SAMPEY JR Am J Pharm Sci Support Public Health; 1963 Dec; 135():451-7. PubMed ID: 14101404 [No Abstract] [Full Text] [Related]
10. Observations on the use of triethylene melamine in Hodgkin's disease. DE ANDINO AM; ROMERO C; RIVERA J; RODRIGUEZ-MOLINA R Bol Asoc Med P R; 1953 Apr; 45(4):107-18. PubMed ID: 13066528 [No Abstract] [Full Text] [Related]
11. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma]. HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965 [No Abstract] [Full Text] [Related]
12. [Triethylene melamine in Hodgkin's disease]. HOST H; QVIGSTAD G Nord Med; 1955 Sep; 54(36):1383-5. PubMed ID: 13266133 [No Abstract] [Full Text] [Related]
13. Triethylene melamine in the treatment of neoplastic disease. RUNDLES RW; BARTON WB Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143 [No Abstract] [Full Text] [Related]
14. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease. HAMBLY CK; ROBERTSON TI Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982 [No Abstract] [Full Text] [Related]
15. [Immediate results of triethylene melamine therapy of neoplastic diseases]. LENTI G; GAVOSTO F Minerva Med; 1953 Jan; 44(1-2):1-19. PubMed ID: 13054386 [No Abstract] [Full Text] [Related]
16. Triethylene melamine in the treatment of Hodgkin's disease and other lymphomas. ROTTINO A N Y State J Med; 1952 Feb; 52(3):346-8. PubMed ID: 14899689 [No Abstract] [Full Text] [Related]
17. Triethylene melamine therapy in Hodgkin's and other malignant diseases. HANSEN PB; BICHEL J Acta Radiol (Stockh); 1951 Dec; 36(6):469-76. PubMed ID: 14902588 [No Abstract] [Full Text] [Related]
18. [Treatment of Hodgkin's disease with triethylene melamine; preliminary report]. BOLIO MONSREAL E Bol Liga Contra Cancer Havana; 1953 Jun; 28(3):56-62. PubMed ID: 13115509 [No Abstract] [Full Text] [Related]